HIF1A and hepatocellular carcinoma: Our findings indicate that USP14 as a deubiquitinase is involved in maintaining HIF1-α stability and enhancement of HIF1-α activity, suggesting USP14 would be a potential diagnosis biomarker and therapeutic target for HCC.